139 related articles for article (PubMed ID: 15214120)
1. Care map. 3: Atypical antipsychotics. Hyperlipidaemia/cardiovascular disease.
Houltram B; Scanlan M
Nurs Stand; 2004 Jun 9-15; 18(39):43-4. PubMed ID: 15214120
[No Abstract] [Full Text] [Related]
2. Care map 5: atypical antipsychotics. Postural hypotension.
Houltram B; Scanlan M
Nurs Stand; 2004 Jun 23-29; 18(41):40-2. PubMed ID: 15314918
[No Abstract] [Full Text] [Related]
3. Managing patients with antipsychotic drug-induced hyperprolactinaemia.
Jones A; Jones M
Nurs Stand; 2008 Oct 15-21; 23(6):48-55; quiz 56. PubMed ID: 18988568
[TBL] [Abstract][Full Text] [Related]
4. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.
Meltzer HY; Davidson M; Glassman AH; Vieweg WV
J Clin Psychiatry; 2002; 63 Suppl 9():25-9. PubMed ID: 12088173
[TBL] [Abstract][Full Text] [Related]
5. Care maps: atypical antipsychotics. Introduction.
Houltram B; Scanlan M
Nurs Stand; 2004 May 19-25; 18(36):42-4. PubMed ID: 15176111
[No Abstract] [Full Text] [Related]
6. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
[No Abstract] [Full Text] [Related]
7. Care map. 2: Atypical antipsychotics. Diabetes and hyperglycaemia.
Houltram B; Scanlan M
Nurs Stand; 2004 Jun 2-8; 18(38):41-2. PubMed ID: 15199709
[No Abstract] [Full Text] [Related]
8. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
Kilbourne AM; Post EP; Bauer MS; Zeber JE; Copeland LA; Good CB; Pincus HA
J Affect Disord; 2007 Sep; 102(1-3):145-51. PubMed ID: 17276514
[TBL] [Abstract][Full Text] [Related]
9. Care map. 1: Atypical antipsychotics. Weight gain.
Houltram B; Scanlan M
Nurs Stand; 2004 May 26-Jun 1; 18(37):41-2. PubMed ID: 15198021
[No Abstract] [Full Text] [Related]
10. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
Glassman AH
J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
[TBL] [Abstract][Full Text] [Related]
11. Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes.
Edward KL; Rasmussen B; Munro I
Arch Psychiatr Nurs; 2010 Feb; 24(1):46-53. PubMed ID: 20117688
[TBL] [Abstract][Full Text] [Related]
12. Monitoring for metabolic complications associated with atypical antipsychotics.
Farver D
S D J Med; 2005 Feb; 58(2):53-4. PubMed ID: 15756776
[No Abstract] [Full Text] [Related]
13. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.
Barnett AH; Mackin P; Chaudhry I; Farooqi A; Gadsby R; Heald A; Hill J; Millar H; Peveler R; Rees A; Singh V; Taylor D; Vora J; Jones PB
J Psychopharmacol; 2007 Jun; 21(4):357-73. PubMed ID: 17656425
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotic therapy and hyperlipidemia: a review.
Koro CE; Meyer JM
Essent Psychopharmacol; 2005; 6(3):148-57. PubMed ID: 15869022
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics: enhancing healthy outcomes.
Casey DE
Arch Psychiatr Nurs; 2002 Jun; 16(3 Suppl 1):S12-9. PubMed ID: 12046020
[No Abstract] [Full Text] [Related]
16. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk factors among forensic patients in the acute psychiatric ward.
Sazhin V; Reznik R
Aust N Z J Psychiatry; 2008 Mar; 42(3):254. PubMed ID: 18247202
[No Abstract] [Full Text] [Related]
18. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risks of atypical antipsychotic drug treatment.
Drici MD; Priori S
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):882-90. PubMed ID: 17563919
[TBL] [Abstract][Full Text] [Related]
20. Schizophrenia and comorbid metabolic disorders.
Henderson DC
J Clin Psychiatry; 2005; 66 Suppl 6():11-20. PubMed ID: 16107179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
